7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Fulya Ağaoğlu, MD Radiation Oncology · Acibadem Atakent Hospital, İstanbul

Prof. Fulya Ağaoğlu, MD

✓ Medically verified profile
Radiation Oncology · Acibadem Atakent Hospital, İstanbul

Prof. Fulya Ağaoğlu, MD

Prof. Fulya Ağaoğlu, MD is a Radiation Oncology specialist at Acibadem Atakent Hospital in İstanbul, Turkey. She plans and delivers radiotherapy, including brachytherapy, for patients with head and neck cancers, brain tumors, breast cancer and gastrointestinal cancers. She has more than 33 years in medicine and consults in Turkish and English, with interpreters available for other languages.

Medically verified profile 33+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Ağaoğlu Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Fulya Ağaoğlu, MDAccepting international patients
SpecialtyRadiation Oncology
ConsultationVideo · In person · Second opinion
Profile

About Prof. Fulya Ağaoğlu, MD

Prof. Fulya Ağaoğlu, MD is a radiation oncologist working in the Radiation Oncology unit at Acibadem Atakent Hospital in İstanbul. She has more than 33 years in medicine. Her clinical work centers on radiotherapy for patients with cancer, including head and neck cancers, brain tumors, breast cancer and gastrointestinal cancers, as well as brachytherapy.

Dr. Ağaoğlu graduated from İstanbul University İstanbul Faculty of Medicine in 1993 and completed her specialty training in Radiation Oncology at the same faculty in 1997. In 1995 she spent time as an observer at Royal Marsden Hospital in London. She was appointed Associate Professor in 2006 and Professor in 2013. In 2009 she served as Chief Physician of the Oncology Institute, and in 2010 she took on responsibility for revenue administration and general administration processes at the institute. She joined Acıbadem Healthcare Services in 2013. She is a member of the Turkish Oncology Association, Turk Radyasyon Onkolojisi Dernegi and the Thoracic Oncology Association. Her co-authored publications in peer-reviewed journals cover topics such as recurrent Ewing sarcoma family tumors and diffuse intrinsic pontine glioma in pediatric patients, circulating microRNAs and plasma markers in prostate cancer, solitary plasmacytoma, soft tissue sarcomas of the head and neck region, and rhabdomyosarcoma in adolescent and adult patients.

Clinical focus

Dr. Ağaoğlu evaluates and plans radiotherapy for a range of cancers. Her areas of expertise include head and neck cancers, brain tumors, breast cancer and gastrointestinal oncology. In these settings, radiotherapy may be considered on its own or alongside surgery and systemic treatment, depending on the diagnosis, the stage of disease and the patient’s overall condition. Decisions on whether radiotherapy is appropriate, and in what form, are made after a review of the individual case.

She also performs brachytherapy, a form of radiotherapy in which a radiation source is placed inside or close to the area being treated. Whether external radiotherapy, brachytherapy or a combination is suitable is determined case by case, taking into account the tumor site, previous treatments and imaging findings.

How Dr. Ağaoğlu works with international patients

Dr. Ağaoğlu speaks Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the possible options. Video consultation is available for international patients who wish to discuss their situation before traveling, although a final treatment plan generally depends on an in-person assessment and up-to-date imaging.

Clinical focus

What Dr. Ağaoğlu treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Areas of practiceGastrointestinal oncology

Background

Education, career and memberships

Education & training

Education

  • 2013Professor
  • 2006Associate Professor
  • 1997İstanbul University İstanbul Faculty of Medicine Radyasyon Onkolojisi
  • 1993İstanbul University İstanbul Faculty of Medicine
Career

Professional Experience

  • 2013Acıbadem Healthcare Services
  • 2010Oncology Institute Revenue Administration and General Administration Processes Officer
  • 2009Chief Physician of the Oncology Institute
  • 1995Royal Marsden Hospital,London / Observer
Memberships

Professional Memberships

  • Turkish Oncology Association
  • Turk Radyasyon Onkolojisi Dernegi
  • Thoracic Oncology Association
Selected publications

Selected Publications

  • 1. A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors Pediatr Hematol Oncol. 2013 Apr:30(3): 170-7 Kebudi R, Cakir FB, Gorgun 0. Agaoglu FY, Darendeliler E
  • Pediatric diffuse intrinsic pontine glioma patients from a single center Childs Neiv Sysl. 2012 Dec 8. (correspondence) Kebudi R Cakir FB, Agaoglu FY, Gorgun O, Ayan I, Darendeliler E.
  • Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management. Journal of Otolaryngology 2012 May-Jun;22(3): 164-71 Dagoglu RN, Ozdemir 0, Ergen A.Agaoglu FY.
  • A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. ScienlificWorldJoumal 2012 (correspondence) Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A.
  • Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumor Biol. 2011 Jun:32(3):583-8. Yaman Agaoglu F, Kovancilar M, Dizdar Y. Darendeliler E, Holdenneder S. Dalay N, Gezer U.
  • 6. Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey. Jpn J Clin Oncol. 2011 Dec;41(12):1380-7. A Single-center Study in Turkey.Yildiz I, Sen F, Basaran M, Ekenel M, Agaoglu F, Darendeliler E, Tune HM, Ozcan F, Bavbek S.
  • 7. Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clin Chim Ada. 2010 Ocl 9;411(19-20):1452-6. Deligezer U, Yaman F. Darendeliler E, Dizdar Y, Holdenrieder S. Kovancilar M, Dalay N.
  • 8. The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases. J Craniomaxillofac Surg. 2009 Jan;37(1):42-8. Fayda M, Aksu G, Yaman Agaoglu F, Karadeniz A, Darendeliler E, Altun M, Hafiz G.
  • 9. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party. Haydaroglu A. Turkish Oncology Group-Sarcoma Working Parly. Am J Hematol.2008 Sep;83(9):702-7. Kilciksiz S, Celik OK, Pak Y, Demiral AN, Pehlivan M, Orhan O, Tokatli F, Agaoglu F, Zincircioglu B, Atasoy BM, Ozseker N, Yersal 0, Niang U,
  • . Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: single center experience from Turkey Tohoku J Exp Med. 2007 Nov;213(3):221-9. Ustuner Z, Basaran M, Dizdar Y, Agaoglu FY, Bilgic B, Sakar B, Basaran GA, Darendeliler E, Ozger II, Onat H, Bavbek S.
Good to Know

Frequently Asked Questions

Which cancers does Dr. Ağaoğlu treat with radiotherapy?
Dr. Ağaoğlu's areas of expertise include head and neck cancers, brain tumors, breast cancer and gastrointestinal oncology. She provides radiotherapy planning and treatment, including brachytherapy. Whether radiotherapy is appropriate for a specific patient depends on the diagnosis, stage and previous treatments, which are reviewed during consultation.
Does Dr. Ağaoğlu perform brachytherapy?
Yes. Brachytherapy, in which a radiation source is placed inside or close to the treated area, is listed among Dr. Ağaoğlu's areas of expertise. Suitability for brachytherapy, external radiotherapy or a combination is decided case by case after reviewing the tumor site, imaging and treatment history.
Where does Dr. Ağaoğlu practice?
Dr. Ağaoğlu works in the Radiation Oncology unit at Acibadem Atakent Hospital in İstanbul, Turkey. She joined Acıbadem Healthcare Services in 2013. Before that, she served as Chief Physician of the Oncology Institute in 2009 and held an administrative role there in 2010.
What documents should I send for a case review with Dr. Ağaoğlu?
It is helpful to provide prior imaging and reports such as MRI, CT, X-ray or ultrasound reports, pathology and laboratory results, operative notes, discharge summaries and details of any previous radiotherapy or systemic treatment. The Acibadem international patient team coordinates the collection of these documents before the consultation.
What is Dr. Ağaoğlu's training and academic background?
Dr. Ağaoğlu graduated from İstanbul University İstanbul Faculty of Medicine in 1993 and completed Radiation Oncology training there in 1997. She was an observer at Royal Marsden Hospital in London in 1995, became Associate Professor in 2006 and Professor in 2013, and has co-authored peer-reviewed publications in oncology.
Can I have a video consultation with Dr. Ağaoğlu before traveling?
Yes, video consultation is available for international patients. It can be used to discuss the history, existing reports and possible options. A definitive radiotherapy plan generally requires an in-person assessment, a clinical examination and up-to-date imaging. Dr. Ağaoğlu speaks Turkish and English, and interpreters can be arranged.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.